Clinical Trial Update: Monitoring, Detoxifying, and Rebalancing Metals During Acute Myeloid Leukemia (AML) Therapy, a Phase 2 Randomized Study [Phase 2]

View source ↗

Summary

Describes a Phase 2 randomized clinical trial at MD Anderson Cancer Center evaluating monitoring, detoxification, and rebalancing of metals during Acute Myeloid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Acute Myeloid Leukemia (AML) | Phase 2 | Status: RECRUITING